Welcome to kongre.net
Speaker
International Medical Director, Novo Nordisk
Susana Rios, International Medical Director at Novo Nordisk, spoke at 10th MASH Drug Development Summit 2026 (Boston, United States of America, 15–17 Sept 2026) in the session “Effect of Efruxifermin on Digital Pathology Fibrosis Measures & Markers of Portal Hypertension in Compensated Cirrhosis Due to Mash”.
15–17 Sept 2026Boston, United States of America
Director, Madrigal Pharmaceuticals
Senior Director, Cellarity
Chief Executive Officer, Cirius Therapeutics
Faculty, Harvard Medical School and Mass General Brigham
Associate Director, Clinical Research, Akero Therapeutics
Vice President, Discovery Biology, Sepia Therapeutics
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Susana Rios, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].